Introduction
CUTISS AG is a leader in personalized, bio-engineered skin tissue therapies, with a focus on innovative solutions for skin conditions such as vitiligo. Their flagship product, VitiCell®, is a pioneering offering in their portfolio.

Exclusive Licensing
CUTISS AG holds the global exclusive license for VitiCell®, positioning them uniquely in the market for advanced vitiligo treatments.

Market Need
There is an increasing demand for advanced treatments for vitiligo, highlighting the unmet need that VitiCell® aims to address.

Support and Expertise
The company provides high-quality support through a dedicated sales team and expertise in pigmentation.

Partnership Opportunities
CUTISS AG is seeking distribution partners for VitiCell® across EMEA, LATAM, and ASPAC regions.

Funding and Resources
The company has secured over 125 million CHF in private and public funding, with a team of 55 full-time employees over 8 years, based in Zurich and with a presence in Sophia-Antipolis, France.

Technological Leadership
CUTISS AG is pioneering in tissue engineering, wound healing, and pigmentation, offering advanced solutions for skin surgery.

Product Positioning
VitiCell® is positioned as an advanced autologous grafting solution for cell-based skin re-pigmentation, specifically designed to treat stable vitiligo at the point-of-care. It is an all-in-one kit that is flexible and provides lasting benefits.

Contact Information
For more information, potential partners and customers can contact the sales team at [email protected] or visit their website at https://cutiss.swiss/contact/.